Efficacy and Safety of BI 1356 in Combination With Metformin in Patients With Type 2 Diabetes

NCT00622284 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1560

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Placebo identical to BI 1356 5mg
DRUG: Placebo identical to Glimepiride 1mg or 2mg or 3mg or 4 mg
DRUG: BI 1356
DRUG: Glimepiride

Sponsor

Boehringer Ingelheim